Evolus (EOLS) Interest Expenses (2021 - 2026)
Evolus (EOLS) reported Interest Expenses of $4.0 million for Q1 2026, down 9.97% on a YoY basis from $4.4 million in Q1 2025, and little changed quarter-over-quarter from $4.0 million in Q4 2025.
Evolus (EOLS) Interest Expenses (2021 - 2026) Analysis & Trends
Evolus has reported Interest Expenses for 6 years, with the latest figure at $4.0 million in Q1 2026.
- For the quarter ending Q1 2026, Interest Expenses fell 9.97% year-over-year to $4.0 million; the trailing twelve-month figure through Mar 2026 stood at $19.3 million (up 4.37% YoY), and the FY2025 full-year result was $19.7 million, up 5.12% from the prior year.
- Interest Expenses for Q1 2026 stood at $4.0 million, roughly flat from $4.0 million in the prior quarter.
- The five-year high for Interest Expenses was $7.2 million in Q2 2025, with the low at $2.0 million in Q1 2022.
- Historically, Interest Expenses has averaged $3.8 million across 5 years, with a median of $4.0 million in 2025.
- Annual changes were most pronounced in 2022 — Interest Expenses soared 1779.29% — and 2025, when it decreased 14.06%.
- Evolus' Interest Expenses stood at $2.6 million in 2022, then jumped by 54.88% to $4.1 million in 2023, then increased by 12.22% to $4.6 million in 2024, then dropped by 13.01% to $4.0 million in 2025, then declined by 0.08% to $4.0 million in 2026.
- The last three Interest Expenses figures came in at $4.0 million (Q1 2026), $4.0 million (Q4 2025), and $4.1 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | - |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 62.00 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 3.00 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 57.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 20.89 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 4.86 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | - |
| 10 | Evolus | 435.45 Mn | 385.65 Mn | 48.90 Mn | 3.98 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.98 Mn |
| Mar 31, 2026 | 3.98 Mn |
| Dec 31, 2025 | 3.98 Mn |
| Dec 31, 2025 | 3.98 Mn |
| Sep 30, 2025 | 4.09 Mn |
| Sep 30, 2025 | 4.09 Mn |
| Jun 30, 2025 | 7.21 Mn |
| Jun 30, 2025 | 7.21 Mn |
| Mar 31, 2025 | 4.42 Mn |
| Mar 31, 2025 | 4.42 Mn |
| Dec 31, 2024 | 4.57 Mn |
| Dec 31, 2024 | 4.57 Mn |
| Sep 30, 2024 | 4.76 Mn |
| Sep 30, 2024 | 4.76 Mn |
| Jun 30, 2024 | 4.70 Mn |
| Jun 30, 2024 | 4.70 Mn |
| Mar 31, 2024 | 4.70 Mn |
| Mar 31, 2024 | 4.70 Mn |
| Dec 31, 2023 | 4.08 Mn |
| Dec 31, 2023 | 4.08 Mn |